RNA-AUFREINIGUNGSVERFAHREN

Patent europeic · EP2970948 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2970948
Numer da la dumonda
EP14709704
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
13-03-2014
Publitgà
20-01-2016
Concedì
26-12-2018
La protecziun finescha il pli tard
12-03-2034
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
C12N 15/10 (2006.01)
C12Q 1/68 (2018.01)
Prioritad
US 201361799705 P 15.03.2013
Dumonda PCT
PCT/EP2014/055014 13.03.2014
Publicaziun PCT
WO2014/140211 18.09.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  4. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  5. 18-01-2019

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 18.01.2019

  6. 07-01-2019

    Concedì

    Published in Swissreg on 07.01.2019

Partidas

Possessur

GlaxoSmithKline Biologicals SA

Rue de l'Institut 89, 1330 Rixensart, BE

Represchentant

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventur

BERLANDA SCORZA, Francesco

Holly Springs, North Carolina 27540, US

GEALL, Andrew

Cambridge, Massachusetts 02139, US

PORTER, Frederick

Holly Springs, North Carolina 27540, US

WEN, Yingxia

Cambridge, Massachusetts 02139, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.